New Delhi, Apr 28 (PTI) Aurobindo Pharma on Monday said a fire incident occurred at the Andhra Pradesh-based plant of its subsidiary Lyfius Pharma on April 27, leading to temporary suspension of operations.

The incident resulted in damage to certain ancillary equipment with no impact on the core manufacturing infrastructure at the Penicillin-G production facility located in Kakinada, the Hyderabad-based drug maker said in a regulatory filing.

Also Read | Analogue Paneer: Consumer Affairs Ministry Mulls Guidelines on Labelling 'Analogue Paneer' as 'Non-Dairy' in Hotels, Restaurants.

Importantly, there were no injuries reported, it added.

"As a precautionary measure and to facilitate necessary equipment replacements, operations at the plant will be temporarily paused for an estimated period of 20 to 25 days," the company said.

Also Read | Bodoland Lottery Result Today, April 28, 2025: Assam State Lottery Sambad Monday Lucky Draw Results Declared, Check Winners List With Ticket Numbers.

A thorough assessment of the damage is currently underway, it added.

"We remain committed to resuming full operations at the earliest," Aurobindo Pharma said.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)